Reference | 1: Cook LB, Rowan AG, Demontis MA, Sagawe S, Gillet NA, Melamed A, Greiller C,
Witkover A, Bangham CRM, Taylor GP. Long-term clinical remission maintained after
cessation of zidovudine and interferon-α therapy in chronic adult T-cell
leukemia/lymphoma. Int J Hematol. 2017 Oct 31. doi: 10.1007/s12185-017-2361-7.
[Epub ahead of print] PubMed PMID: 29090417.
<br>
2: Pîrnău A, Mic M, Neamţu S, Floare CG, Bogdan M. Calorimetric and spectroscopic
studies of the interaction between zidovudine and human serum albumin.
Spectrochim Acta A Mol Biomol Spectrosc. 2017 Oct 10;191:226-232. doi:
10.1016/j.saa.2017.10.032. [Epub ahead of print] PubMed PMID: 29040928.
<br>
3: Alzate Angel JC, Duque Molina MM, García García HI. Zidovudine/Lamivudine vs.
Abacavir/Lamivudine vs. Tenofovir/Emtricitabine in fixed-dose combinations as
initial treatment for HIV patients: a systematic review and network
meta-analysis. Colomb Med (Cali). 2017 Jun 30;48(2):70-81. PubMed PMID: 29021641;
PubMed Central PMCID: PMC5625561.
<br>
4: Ng SMS, Sioson JSP, Yap JM, Ng FM, Ching HSV, Teo JWP, Jureen R, Hill J, Chia
CSB. Repurposing Zidovudine in combination with Tigecycline for treating
carbapenem-resistant Enterobacteriaceae infections. Eur J Clin Microbiol Infect
Dis. 2017 Oct 10. doi: 10.1007/s10096-017-3114-5. [Epub ahead of print] PubMed
PMID: 29019016.
<br>
5: Ramanathan R, Sivanesan K. Investigations on the Influence of Zidovudine in
the Pharmacokinetics of Isoniazid and Its Hepatotoxic Metabolites in Rats. J
Pharm Pract. 2017 Jan 1:897190017735424. doi: 10.1177/0897190017735424. [Epub
ahead of print] PubMed PMID: 29017426.
<br>
6: Serrano-Villar S, Caruana G, Zlotnik A, Pérez-Molina JA, Moreno S. The effects
of maraviroc versus efavirenz in combination with zidovudine/lamivudine on the
CD4/CD8 ratio in treatment-naïve HIV-infected individuals. Antimicrob Agents
Chemother. 2017 Oct 9. pii: AAC.01763-17. doi: 10.1128/AAC.01763-17. [Epub ahead
of print] PubMed PMID: 28993335.
<br>
7: Joshy KS, Susan MA, Snigdha S, Nandakumar K, Laly AP, Sabu T. Encapsulation of
zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug
delivery. Int J Biol Macromol. 2017 Sep 20. pii: S0141-8130(17)30831-0. doi:
10.1016/j.ijbiomac.2017.09.078. [Epub ahead of print] PubMed PMID: 28939525.
<br>
8: Bosire R, Farquhar C, Nduati R, Broliden K, Luchters S, Van de Perre P, De
Vincenzi I, Merkel M, Wachuka V, Mbori-Ngacha D, John-Stewart G, Lohman-Payne B,
Reilly M. Higher Transplacental Pathogen-Specific Antibody Transfer Among
Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course
Zidovudine. Pediatr Infect Dis J. 2017 Aug 19. doi: 10.1097/INF.0000000000001749.
[Epub ahead of print] PubMed PMID: 28834955.
<br>
9: Yan JK, Wang YY, Qiu WY, Wu JY. Construction and characterization of nanosized
curdlan sulfate/chitosan polyelectrolyte complex toward drug release of
zidovudine. Carbohydr Polym. 2017 Oct 15;174:209-216. doi:
10.1016/j.carbpol.2017.06.082. Epub 2017 Jun 23. PubMed PMID: 28821060.
<br>
10: Mashingaidze F, Choonara YE, Kumar P, du Toit LC, Maharaj V, Buchmann E,
Pillay V. Submicron Matrices Embedded in a Polymeric Caplet for Extended
Intravaginal Delivery of Zidovudine. AAPS J. 2017 Aug 4. doi:
10.1208/s12248-017-0130-4. [Epub ahead of print] PubMed PMID: 28779379.
|